脑部放疗,上午比下午敏感许多!) k" T4 O) T- B' m F3 u# g; L
( ~+ Z! W: C; ?+ ^, I' [8 g9 _
6 R7 \" K9 J4 y$ D! g2 F R4 Z& GCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
3 ~3 i( C, d. H; ~. p: ^* g! jGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?5 y0 W8 j0 [- ]7 q4 B' M( U
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.2 l+ V% @9 V* \5 M. @2 y
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
$ L. j2 U8 Z" o) O$ s( y8 k6 O+ Y0 ~
" J4 p* z, G; j6 AAbstract: e1 z- l- ^7 v7 A
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.2 ]) j5 B1 i% j
7 o! K7 D) `) a' w- Q2 e1 v
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
" [ |2 f8 g3 _, n `; i6 H
' P3 C9 C& W5 B8 W) X0 A3 j1 tRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).- B6 @4 Q' W6 U+ B+ t5 x' S, e4 V
$ o; h( F$ t F$ D, B# |CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
4 U) o1 z- r5 [3 `0 }. c/ r) c4 P C) O, H; @' g" [
|